Emibetuzumab (Anti-HGFR / c-Met)

Ask supplier a question | View on supplier's website

Emibetuzumab (Anti-HGFR / c-Met) is a humanized bivalent MET antibody targeting both HGF-dependent and HGF-independent MET pathway activation and tumor growth. It can be used in study of cancer. MW :144.56 KD.

Supplier	Selleck Chemicals
Product #	A2662
Sku #	A2662-1mg*5
Pricing	1mg*5, $790.00

Feedback